My account
Subscribe
Advertisement
KEMPHARM, INC.
KemPharm, Inc. Receives Patent from the USPTO for Novel Pain Drug Candidate, KP201
Rubrique: Health Business news
[2013-06-11] -
KemPharm's KP201 Featured at the International Conference on Opioids
Rubrique: Health Business news
[2013-06-04] - Poster Presentation to Highlight KP201's Unique Abuse-Deterrent Properties and Its Potential to Prevent or Reduce Opioid-Induced Constipation
Advertisement
Most read: scientific news
More:
Market news
Latest news:
- New Banfield Pet Hospital Research Reveals One In Three U.S. Pets Is Overweight
- U.S. News & World Report Announces the 2017-2018 Best Children's Hospitals
- Regeneron and Sanofi Announce Approval of Kevzara® (sarilumab) to Treat Adult Patients with Moderately to Severely Active Rheumatoid Arthritis in the European Union
Toutes les entreprises de la santé
Follow us...
Actualités
Actualités
Actualités
Réglementaire
Emploi
Annuaires
Dictionnaire
Divers
I-professionnel.com Health / Medical, technical and professional medical news - health every day ...
Home portail - Contact - Mentions légales - Copyright © 2013